Journal of Vascular Surgery
Volume 51, Issue 1 , Pages 165-173 , January 2010

Endothelial nitric oxide synthase affects both early and late collateral arterial adaptation and blood flow recovery after induction of hind limb ischemia in mice

  • Brian Park, MD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • Ari Hoffman, MD

      Affiliations

    • University of California at San Francisco, San Francisco, Calif
  • ,
  • Yagai Yang, PhD

      Affiliations

    • University of California at San Francisco, San Francisco, Calif
  • ,
  • Jinglian Yan, PhD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • Guodong Tie, PhD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • Hossein Bagshahi, MD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • Philip T. Nowicki, MD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School, Worcester, Mass
  • ,
  • Louis M. Messina, MD

      Affiliations

    • Division of Vascular Surgery, University of Massachusetts Medical School, Worcester, Mass
    • Corresponding Author InformationReprint requests: Louis M. Messina, MD, University of Massachusetts Medical School, 55 Lake Ave N, Worcester, MA 01655

Received 20 May 2009 ,Accepted 12 August 2009.

References 

  1. Schainfeld RM, Isner JM. Critical limb ischemia: nothing to give at the office?. Ann Intern Med. 1999;130:442–444
  2. Helisch A, Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation. 2003;10:83–97
  3. Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T, et al. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol. 2002;34:775–787
  4. Cooke JP. Flow, NO, and atherogenesis. Proc Natl Acad Sci. 2003;100:768–770
  5. Pipp F, Boehm S, Cai WJ, Adili F, Ziegler B, Karanovic G, et al. Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hindlimb. Arterioscler Thromb Vasc Biol. 2004;24:1664–1668
  6. Voskuil M, van Royen N, Hoefer IE, Seidler R, Guth BD, Bode C, et al. Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am J Physiol Heart Circ Physiol. 2003;284:H1422–H1428
  7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967
  8. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95:343–353
  9. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004;94:678–685
  10. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med. 2006;12:557–567
  11. Mees B, Wagner S, Ninci E, Tribulova S, Martin S, van Haperen R, et al. Endothelial nitric oxide synthase activity is essential for vasodilation during blood flow recovery but not for arteriogenesis. Arterioscler Thromb Vasc Biol. 2007;27:1–8
  12. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Mede. 2003;9:1370–1376
  13. Kaminski A, Ma N, Donndorf P, Lindenblatt N, Feldmeier F, Ong L, et al. Endothelial NOS is required for SDF-1α/CXCR4-mediated peripheral endothelial adhesion of c-Kit+ bone marrow stem cells. Lab Invest. 2008;88:58–69
  14. Rafii D, Psaila B, Butler J, Jin DK, Lyden D. Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells. Arterioscler Thromb Vasc Biol. 2008;28:217–222
  15. Wragg A, Mellad J, Beltran L, Konoplyannikov M, San H, Boozer S, et al. VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med. 2008;86:1221–1232
  16. Tang GL, Chang DS, Sarkar R, Wang R, Messina LM. The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia. J Vasc Surg. 2005;41:312–320
  17. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567–2568
  18. Eitenmuller I, Volger O, Kluge A, Troidl K, Barancik M, Cai WJ, et al. The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res. 2006;99:656–662
  19. Yu J, Demuink E, Zhuang Z, Drinane M, Kauser K, Rubanyi G, et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci. 2005;102:10999–11004
  20. Smith R, Lin K-F, Agata J, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arterioscler Thromb Vasc Biol. 2002;22:1279–1285
  21. Brevetti LS, Chang DS, Tang GL, Sarkar R, Messina LM. Overexpression of endothelial nitric oxide synthase increases skeletal muscled blood flow and oxygenation in severe rat hind limb ischema. J Vasc Surg. 2003;38:820–826
  22. Van Weel V, Toes RE, Seghers L, Deckers MR, de Vries PH, Eilers J, et al. Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler Thromb Vasc Biol. 2007;27:2310–2318
  23. Alderton WK, Cooper CE, Kowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:593–615
  24. Heil M, Ziegelhoeffer T, Mees B, Schaper W. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res. 2004;94:573–574
  25. Böger R, Bode-Böger S, Thiele W, Junker W, Alexander K, Frölich J. Biochemical evidence of impaired nitric oxide synthesis in patients with peripheral arterial disease. Circulation. 1997;95:2068–2073
  26. Henry T, Annex B, McKendall G, Azarin M, Lopex J, Giordano F, et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation. 2003;107:1359–1365
  27. Simons M, Annex B, Laham R, Kleiman N, Henry T, Dauerman H, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002;105:788–793
  28. Hiasa KI, Ishibashi M, Ohtani K, Inuoe S, Zhao Q, Kitamoto S, et al. Gene transfer of stromal cell-derived factor-1a enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation. 2004;109:2454–2461
  29. Ahmad S, Hewett PW, Wang P, Al-Ani B, Cudmore M, Fujisawa T, et al. Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res. 2006;99:715–722

 This work was funded by HL75353 to Dr Messina.

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)01686-3

doi: 10.1016/j.jvs.2009.08.045

Journal of Vascular Surgery
Volume 51, Issue 1 , Pages 165-173 , January 2010